| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentals
|
Debotton, Nir
|
|
2014
|
19 |
9 |
p. 1322-1336
15 p.
|
artikel
|
| 2 |
An analysis of FDA-approved drugs for infectious disease: antibacterial agents
|
Kinch, Michael S.
|
|
2014
|
19 |
9 |
p. 1283-1287
5 p.
|
artikel
|
| 3 |
Animal models of invasive aspergillosis for drug discovery
|
Paulussen, Caroline
|
|
2014
|
19 |
9 |
p. 1380-1386
7 p.
|
artikel
|
| 4 |
Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases
|
Kanwar, Jagat R.
|
|
2014
|
19 |
9 |
p. 1309-1321
13 p.
|
artikel
|
| 5 |
CANDO and the infinite drug discovery frontier
|
Minie, Mark
|
|
2014
|
19 |
9 |
p. 1353-1363
11 p.
|
artikel
|
| 6 |
Content page 2
|
|
|
2014
|
19 |
9 |
p. iv-
1 p.
|
artikel
|
| 7 |
Contents page 1
|
|
|
2014
|
19 |
9 |
p. i-
1 p.
|
artikel
|
| 8 |
Contents page 1
|
|
|
2014
|
19 |
9 |
p. iii-
1 p.
|
artikel
|
| 9 |
Deciphering molecular determinants of chemotherapy in gastrointestinal malignancy using systems biology approaches
|
Lin, Li-Ling
|
|
2014
|
19 |
9 |
p. 1402-1409
8 p.
|
artikel
|
| 10 |
Delivery of epidrugs
|
el Bahhaj, Fatima
|
|
2014
|
19 |
9 |
p. 1337-1352
16 p.
|
artikel
|
| 11 |
Enabled clinical use of an HIV-1 attachment inhibitor through drug delivery
|
Timmins, Peter
|
|
2014
|
19 |
9 |
p. 1288-1293
6 p.
|
artikel
|
| 12 |
Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy
|
Kwa, Faith A.A.
|
|
2014
|
19 |
9 |
p. 1387-1393
7 p.
|
artikel
|
| 13 |
Factor IXa as a target for anticoagulation in thrombotic disorders and conditions
|
Smiley, Dia A.
|
|
2014
|
19 |
9 |
p. 1445-1453
9 p.
|
artikel
|
| 14 |
Factor XI as a target for antithrombotic therapy
|
Bane Jr., Charles E.
|
|
2014
|
19 |
9 |
p. 1454-1458
5 p.
|
artikel
|
| 15 |
Factor XII: a drug target for safe interference with thrombosis and inflammation
|
Kenne, Ellinor
|
|
2014
|
19 |
9 |
p. 1459-1464
6 p.
|
artikel
|
| 16 |
Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies
|
‘t Hart, Bert A.
|
|
2014
|
19 |
9 |
p. 1394-1401
8 p.
|
artikel
|
| 17 |
Inhibition of Factor XI activity as a promising antithrombotic strategy
|
Chen, Zhu
|
|
2014
|
19 |
9 |
p. 1435-1439
5 p.
|
artikel
|
| 18 |
Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: a psoriasis case study
|
Qu, Xiaoyan A.
|
|
2014
|
19 |
9 |
p. 1364-1371
8 p.
|
artikel
|
| 19 |
Melatonin: functions and ligands
|
Singh, Mahaveer
|
|
2014
|
19 |
9 |
p. 1410-1418
9 p.
|
artikel
|
| 20 |
Minding the gaps in tuberculosis research
|
Ekins, Sean
|
|
2014
|
19 |
9 |
p. 1279-1282
4 p.
|
artikel
|
| 21 |
New advances in treating thrombotic diseases
|
Schumacher, William A.
|
|
2014
|
19 |
9 |
p. 1433-1434
2 p.
|
artikel
|
| 22 |
New advances in treating thrombotic diseases: GPVI as a platelet drug target
|
Jiang, Peng
|
|
2014
|
19 |
9 |
p. 1471-1475
5 p.
|
artikel
|
| 23 |
Novel or expanding current targets in fibrinolysis
|
Wyseure, Tine
|
|
2014
|
19 |
9 |
p. 1476-1482
7 p.
|
artikel
|
| 24 |
Personalizing prostate cancer therapy: the way forward
|
Cetnar, Jeremy P.
|
|
2014
|
19 |
9 |
p. 1483-1487
5 p.
|
artikel
|
| 25 |
Physicochemical modifications of histones and their impact on epigenomics
|
Andreoli, Federico
|
|
2014
|
19 |
9 |
p. 1372-1379
8 p.
|
artikel
|
| 26 |
Reversal of target-specific oral anticoagulants
|
Siegal, Deborah M.
|
|
2014
|
19 |
9 |
p. 1465-1470
6 p.
|
artikel
|
| 27 |
Safety information on QT-interval prolongation: comparison of European Union and United States drug labeling
|
Warnier, Miriam J.
|
|
2014
|
19 |
9 |
p. 1294-1297
4 p.
|
artikel
|
| 28 |
Small-molecule clinical trial candidates for the treatment of glioma
|
Prabhu, Saurabh
|
|
2014
|
19 |
9 |
p. 1298-1308
11 p.
|
artikel
|
| 29 |
Strategies for targeting the androgen receptor axis in prostate cancer
|
Carver, Brett S.
|
|
2014
|
19 |
9 |
p. 1493-1497
5 p.
|
artikel
|
| 30 |
Sulforaphane and prostate cancer interception
|
Traka, Maria H.
|
|
2014
|
19 |
9 |
p. 1488-1492
5 p.
|
artikel
|
| 31 |
Synergizing immunotherapy with molecular-targeted anticancer treatment
|
Fernández, Ariel
|
|
2014
|
19 |
9 |
p. 1427-1432
6 p.
|
artikel
|
| 32 |
The emerging role of speckle-type POZ protein (SPOP) in cancer development
|
Mani, Ram-Shankar
|
|
2014
|
19 |
9 |
p. 1498-1502
5 p.
|
artikel
|
| 33 |
Therapeutic strategies for treating osteolytic bone metastases
|
Verron, Elise
|
|
2014
|
19 |
9 |
p. 1419-1426
8 p.
|
artikel
|
| 34 |
Tissue factor–fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic
|
Priestley, E. Scott
|
|
2014
|
19 |
9 |
p. 1440-1444
5 p.
|
artikel
|
Tijdschrift beschrijving